Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-064727

Options or other derivatives

  • Director acquired 25,133 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Incerti Carlo Director 2024-05-22 Grant or award · Stock option (right to buy) +25,133 25,133 D
Loading xslF345X05/ownership.xml…